Stroke
Conditions
Interventions
Treated with Maixuekang and Maizhiling:None
Conventional western medicine anticoagulants therapy:None
Sponsors
the First People's Hospital of Chongqing Liangjiang New Area
Eligibility
Sex/Gender
All
Age
30 Years to 90 Years
Inclusion criteria
Inclusion criteria: ? Referring to the 2010 edition of "Guidelines for the Prevention and Treatment of Cerebrovascular Diseases in China", and diagnosed with cerebral infarction or cerebral hemorrhage by head computed tomography (CT) or magnetic resonance imaging (MRI), patients was in the recovery period (duration from 2 weeks to 6 months) with the condition basically stable. ? Patients had lower extremity venous thrombosis diagnosed by color Doppler ultrasonography.
Exclusion criteria
Exclusion criteria: ? Patients with progressive stroke or unstable vital signs in the acute stage, ? Patients with severe cognitive impairment, audio-visual and speech impairment, coma, mental illness or post-stroke depression, ? Patients with history of alcoholism and psychotropic drug dependence, ? Patients with malignant tumors, brain tumors, brain trauma, and other blood system diseases, ? Patients with severe heart, lung, liver, and renal insufficiency, ? Patients with other or severe coagulation disorders.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| General condition;Type of thrombus;Whether the thrombus disappeared after treatment;Whether bleeding or stomach discomfort occurred during treatment;Coagulation function;D-dimer;Fibrinogen;Platelets;Thromboelastography; | — |
Countries
China
Contacts
Public ContactSun Lin
the first people's Hospital of Chongqing Liangjiang New Area,Liangjiang New Area Chongqing
Outcome results
None listed